ELITE PHARMACEUTICALS INC /NV/ ELTP

Name: ELTP quality scores
Creator: Stocktoria
License: https://stocktoria.com/terms/

OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2014-02-20

ELITE PHARMACEUTICALS INC /NV/ (ELTP) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2026 revenue was $148.9M at a 30.1% net margin.

6/9

Piotroski F — financial health

7.73

Altman Z″ — distress risk · safe

—

Dividend payout · no dividend

$0.39 as of 2026-06-01 · -46.6% 1y

$0.34$0.7352-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap$425M

P / E9.5×

Net margin30.1%

Return on equity45.4%

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1829 companies

Piotroski Fstronger than 77%

Net marginstronger than 96%

Return on equitystronger than 97%

Revenue growthstronger than 96%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 6/9 tests passed

Positive return on assets
Positive operating cash flow
Rising ROA
Cash flow exceeds net income
Lower long-term debt
Rising current ratio
No share dilution
Rising gross margin
Rising asset turnover

Altman Z″ components · safe zone

Component	Value
Working capital / assets	0.685
Retained earnings / assets	-0.548
EBIT / assets	0.355
Equity / liabilities	2.509

Detailed pages

FinancialsELTP financials StatisticsELTP statistics

Sector peers · similar-size Manufacturing companies

Ticker	Company	Piotroski F	Altman Z″	P / E	Revenue growth
ELTP	ELITE PHARMACEUTICALS INC /NV/	6/9	7.73	9.5	+77.1%
MGNX	MACROGENICS INC	2/9	-12.89	—	-0.3%
KPTI	Karyopharm Therapeutics Inc.	2/9	—	—	+0.6%
HRTX	HERON THERAPEUTICS, INC. /DE/	2/9	—	—	+7.4%
LQDA	Liquidia Corp	3/9	-4.36	—	+1031.2%
LFCR	LIFECORE BIOMEDICAL, INC. \DE\	3/9	-1.75	—	+0.5%
XNCR	Xencor Inc	3/9	2.23	—	+13.7%

All Manufacturing companies →

FAQ

Is ELTP financially healthy?

ELITE PHARMACEUTICALS INC /NV/'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does ELTP pay a dividend?

No, ELITE PHARMACEUTICALS INC /NV/ does not currently pay a dividend.

How profitable is ELTP?

In FY2026, ELITE PHARMACEUTICALS INC /NV/ had a net margin of 30.1% and a return on equity of 45.4%.

Source: SEC EDGAR filings · CIK 0001053369 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.